Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.

Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Clin J Oncol Nurs. 2019 Oct 01;23(5):494-501
Authors: Chan YN, Jheng YW, Wang PJ, Chen CY, Lin MW, Wang YJ
Abstract
BACKGROUND: Taxane-induced peripheral neuropathy (TIPN) is caused by the neurotoxicity of paclitaxel and docetaxel, but the differences between paclitaxel- and docetaxel-induced peripheral neuropathy are understudied.
OBJECTIVES: The purpose of this study is to compare TIPN between docetaxel and paclitaxel in patients with breast cancer and to examine the consistency of measuring TIPN between researchers and patients.
METHODS: Secondary data were analyzed from a cross-sectional study that included 64 patients with breast cancer from two teaching hospitals in Taiwan. Objective and subjective TIPN were measured.
FINDINGS: Results indicated significant differences in objective TIPN, sensory sum score, and motor sum score between groups. No significant difference was detected in subjective TIPN between groups.
PMID: 31538967 [PubMed - in process]

Source: Clinical Journal of Oncology Nursing - September 22, 2019 Category: Nursing Authors: Chan YN, Jheng YW, Wang PJ, Chen CY, Lin MW, Wang YJ Tags: Clin J Oncol Nurs Source Type: research